It was announced that Sunzen Biotech will be exiting from its animal health business to focus on human health products and loan financing services. Executive chairman, Ching Chee Pun shares with us the rationale behind this decision, the outlook and why they appear to have a weak track record when it comes to M&A.

Can Marriott Stay Ahead in Malaysia?
22:47

Generational Politics: PKR vs UMNO
22:55

The ASEAN Way: A Blueprint for New Multilateralism?
25:42